CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 53 filers reported holding CATALYST BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,435 | +37.4% | 90,058 | +0.2% | 0.01% | +75.0% |
| Q2 2023 | $31,604 | +69.9% | 89,886 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $18,606 | -61.0% | 89,886 | -0.7% | 0.00% | -71.4% |
| Q4 2022 | $47,730 | +6.1% | 90,484 | +0.3% | 0.01% | -22.2% |
| Q3 2022 | $45,000 | -72.9% | 90,188 | -3.5% | 0.01% | -78.6% |
| Q2 2022 | $166,000 | +137.1% | 93,434 | -11.9% | 0.04% | +82.6% |
| Q1 2022 | $70,000 | -30.7% | 106,089 | -4.4% | 0.02% | -57.4% |
| Q4 2021 | $101,000 | – | 110,991 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
| ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
| 22NW, LP | 735,841 | $4,319,000 | 2.34% |
| Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
| Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
| Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
| Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
| Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
| Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
| Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |